Global Neurological Disorder Drugs Market Growth (Status and Outlook) 2025-2031

October 2025 | 90 pages | ID: G870C19F8F6EEN
LP Information

Abstracts

According to this study, the global Neurological Disorder Drugs market size will reach US$ 4071 million by 2031.

Several government initiatives across various countries to educate masses about the rise of various diseases and increasing healthcare sector producing new drugs are the prime reasons for growth of neurological disorder drugs market. European Parkinson’s Disease Association, in Europe is actively supporting research and development by campaigning to raise awareness, and providing medication to patients is boosting the overall neurological disorder drugs market. This region is also witnessing rising focus on research and development programs that will help in producing affordable and effective drugs. The countries are collectively spending on developing neurological disorder drugs thus, improving the revenue of the market during the forecast period.

Staggering increase in brain altering disorders such as Alzheimer’s, epilepsy, Parkinson’s, cerebrovascular, and sclerosis are promoting the pharmaceutical firms to tap into the significantly growing neurological disorder drugs market. This will potentially supplement the market growth in the coming years. Rise of several innovative drugs to manage these diseases will swell up the investments in the market. Increasing number of clinical trials are another reason boosting the market. Rise in geriatric population along with patients with strokes, migraines, and headaches leading to cerebrovascular diseases are likely to augment the growth of the market.

LPI (LP Information)' newest research report, the “Neurological Disorder Drugs Industry Forecast” looks at past sales and reviews total world Neurological Disorder Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Neurological Disorder Drugs sales for 2025 through 2031. With Neurological Disorder Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurological Disorder Drugs industry.

This Insight Report provides a comprehensive analysis of the global Neurological Disorder Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Neurological Disorder Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurological Disorder Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurological Disorder Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurological Disorder Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Neurological Disorder Drugs market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Antipsychotic
• Hypnotic & Sedative
• Analgesics
• Anticoagulants
• Others

Segmentation by Application:

• Hospital
• Clinic

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novartis
• GlaxoSmithKline
• Merck & Co.
• Bayer
• AstraZeneca
• Boehringer Ingelheim
• Teva Pharmaceutical

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Fiberglass Floor Board Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Fiberglass Floor Board by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Fiberglass Floor Board by Country/Region, 2020, 2024 & 2031
2.2 Fiberglass Floor Board Segment by Type
  2.2.1 Luxury Vinyl Tiles
  2.2.2 Vinyl Composite Tiles
  2.2.3 Vinyl Sheets
2.3 Fiberglass Floor Board Sales by Type
  2.3.1 Global Fiberglass Floor Board Sales Market Share by Type (2020-2025)
  2.3.2 Global Fiberglass Floor Board Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Fiberglass Floor Board Sale Price by Type (2020-2025)
2.4 Fiberglass Floor Board Segment by Application
  2.4.1 Residential
  2.4.2 Commercial
  2.4.3 Industrial
2.5 Fiberglass Floor Board Sales by Application
  2.5.1 Global Fiberglass Floor Board Sale Market Share by Application (2020-2025)
  2.5.2 Global Fiberglass Floor Board Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Fiberglass Floor Board Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Fiberglass Floor Board Breakdown Data by Company
  3.1.1 Global Fiberglass Floor Board Annual Sales by Company (2020-2025)
  3.1.2 Global Fiberglass Floor Board Sales Market Share by Company (2020-2025)
3.2 Global Fiberglass Floor Board Annual Revenue by Company (2020-2025)
  3.2.1 Global Fiberglass Floor Board Revenue by Company (2020-2025)
  3.2.2 Global Fiberglass Floor Board Revenue Market Share by Company (2020-2025)
3.3 Global Fiberglass Floor Board Sale Price by Company
3.4 Key Manufacturers Fiberglass Floor Board Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Fiberglass Floor Board Product Location Distribution
  3.4.2 Players Fiberglass Floor Board Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR FIBERGLASS FLOOR BOARD BY GEOGRAPHIC REGION

4.1 World Historic Fiberglass Floor Board Market Size by Geographic Region (2020-2025)
  4.1.1 Global Fiberglass Floor Board Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Fiberglass Floor Board Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Fiberglass Floor Board Market Size by Country/Region (2020-2025)
  4.2.1 Global Fiberglass Floor Board Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Fiberglass Floor Board Annual Revenue by Country/Region (2020-2025)
4.3 Americas Fiberglass Floor Board Sales Growth
4.4 APAC Fiberglass Floor Board Sales Growth
4.5 Europe Fiberglass Floor Board Sales Growth
4.6 Middle East & Africa Fiberglass Floor Board Sales Growth

5 AMERICAS

5.1 Americas Fiberglass Floor Board Sales by Country
  5.1.1 Americas Fiberglass Floor Board Sales by Country (2020-2025)
  5.1.2 Americas Fiberglass Floor Board Revenue by Country (2020-2025)
5.2 Americas Fiberglass Floor Board Sales by Type (2020-2025)
5.3 Americas Fiberglass Floor Board Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Fiberglass Floor Board Sales by Region
  6.1.1 APAC Fiberglass Floor Board Sales by Region (2020-2025)
  6.1.2 APAC Fiberglass Floor Board Revenue by Region (2020-2025)
6.2 APAC Fiberglass Floor Board Sales by Type (2020-2025)
6.3 APAC Fiberglass Floor Board Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Fiberglass Floor Board by Country
  7.1.1 Europe Fiberglass Floor Board Sales by Country (2020-2025)
  7.1.2 Europe Fiberglass Floor Board Revenue by Country (2020-2025)
7.2 Europe Fiberglass Floor Board Sales by Type (2020-2025)
7.3 Europe Fiberglass Floor Board Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Fiberglass Floor Board by Country
  8.1.1 Middle East & Africa Fiberglass Floor Board Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Fiberglass Floor Board Revenue by Country (2020-2025)
8.2 Middle East & Africa Fiberglass Floor Board Sales by Type (2020-2025)
8.3 Middle East & Africa Fiberglass Floor Board Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Fiberglass Floor Board
10.3 Manufacturing Process Analysis of Fiberglass Floor Board
10.4 Industry Chain Structure of Fiberglass Floor Board

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Fiberglass Floor Board Distributors
11.3 Fiberglass Floor Board Customer

12 WORLD FORECAST REVIEW FOR FIBERGLASS FLOOR BOARD BY GEOGRAPHIC REGION

12.1 Global Fiberglass Floor Board Market Size Forecast by Region
  12.1.1 Global Fiberglass Floor Board Forecast by Region (2026-2031)
  12.1.2 Global Fiberglass Floor Board Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Fiberglass Floor Board Forecast by Type (2026-2031)
12.7 Global Fiberglass Floor Board Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 IVC Group
  13.1.1 IVC Group Company Information
  13.1.2 IVC Group Fiberglass Floor Board Product Portfolios and Specifications
  13.1.3 IVC Group Fiberglass Floor Board Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 IVC Group Main Business Overview
  13.1.5 IVC Group Latest Developments
13.2 Mannington Mills, Inc
  13.2.1 Mannington Mills, Inc Company Information
  13.2.2 Mannington Mills, Inc Fiberglass Floor Board Product Portfolios and Specifications
  13.2.3 Mannington Mills, Inc Fiberglass Floor Board Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Mannington Mills, Inc Main Business Overview
  13.2.5 Mannington Mills, Inc Latest Developments
13.3 Shaw Floors
  13.3.1 Shaw Floors Company Information
  13.3.2 Shaw Floors Fiberglass Floor Board Product Portfolios and Specifications
  13.3.3 Shaw Floors Fiberglass Floor Board Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Shaw Floors Main Business Overview
  13.3.5 Shaw Floors Latest Developments
13.4 NOX Corporation
  13.4.1 NOX Corporation Company Information
  13.4.2 NOX Corporation Fiberglass Floor Board Product Portfolios and Specifications
  13.4.3 NOX Corporation Fiberglass Floor Board Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 NOX Corporation Main Business Overview
  13.4.5 NOX Corporation Latest Developments
13.5 Milliken
  13.5.1 Milliken Company Information
  13.5.2 Milliken Fiberglass Floor Board Product Portfolios and Specifications
  13.5.3 Milliken Fiberglass Floor Board Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Milliken Main Business Overview
  13.5.5 Milliken Latest Developments
13.6 Armstrong World Industries
  13.6.1 Armstrong World Industries Company Information
  13.6.2 Armstrong World Industries Fiberglass Floor Board Product Portfolios and Specifications
  13.6.3 Armstrong World Industries Fiberglass Floor Board Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Armstrong World Industries Main Business Overview
  13.6.5 Armstrong World Industries Latest Developments
13.7 Gerflor
  13.7.1 Gerflor Company Information
  13.7.2 Gerflor Fiberglass Floor Board Product Portfolios and Specifications
  13.7.3 Gerflor Fiberglass Floor Board Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Gerflor Main Business Overview
  13.7.5 Gerflor Latest Developments
13.8 Tarkett
  13.8.1 Tarkett Company Information
  13.8.2 Tarkett Fiberglass Floor Board Product Portfolios and Specifications
  13.8.3 Tarkett Fiberglass Floor Board Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Tarkett Main Business Overview
  13.8.5 Tarkett Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Neurological Disorder Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Neurological Disorder Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Antipsychotic
Table 4. Major Players of Hypnotic & Sedative
Table 5. Major Players of Analgesics
Table 6. Major Players of Anticoagulants
Table 7. Major Players of Others
Table 8. Neurological Disorder Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Neurological Disorder Drugs Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Neurological Disorder Drugs Market Size Market Share by Type (2020-2025)
Table 11. Neurological Disorder Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Neurological Disorder Drugs Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Neurological Disorder Drugs Market Size Market Share by Application (2020-2025)
Table 14. Global Neurological Disorder Drugs Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Neurological Disorder Drugs Revenue Market Share by Player (2020-2025)
Table 16. Neurological Disorder Drugs Key Players Head office and Products Offered
Table 17. Neurological Disorder Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Neurological Disorder Drugs Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Neurological Disorder Drugs Market Size Market Share by Region (2020-2025)
Table 22. Global Neurological Disorder Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Neurological Disorder Drugs Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Neurological Disorder Drugs Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Neurological Disorder Drugs Market Size Market Share by Country (2020-2025)
Table 26. Americas Neurological Disorder Drugs Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Neurological Disorder Drugs Market Size Market Share by Type (2020-2025)
Table 28. Americas Neurological Disorder Drugs Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Neurological Disorder Drugs Market Size Market Share by Application (2020-2025)
Table 30. APAC Neurological Disorder Drugs Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Neurological Disorder Drugs Market Size Market Share by Region (2020-2025)
Table 32. APAC Neurological Disorder Drugs Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Neurological Disorder Drugs Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Neurological Disorder Drugs Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Neurological Disorder Drugs Market Size Market Share by Country (2020-2025)
Table 36. Europe Neurological Disorder Drugs Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Neurological Disorder Drugs Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Neurological Disorder Drugs Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Neurological Disorder Drugs Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Neurological Disorder Drugs Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Neurological Disorder Drugs
Table 42. Key Market Challenges & Risks of Neurological Disorder Drugs
Table 43. Key Industry Trends of Neurological Disorder Drugs
Table 44. Global Neurological Disorder Drugs Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Neurological Disorder Drugs Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Neurological Disorder Drugs Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Neurological Disorder Drugs Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Novartis Details, Company Type, Neurological Disorder Drugs Area Served and Its Competitors
Table 49. Novartis Neurological Disorder Drugs Product Offered
Table 50. Novartis Neurological Disorder Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Novartis Main Business
Table 52. Novartis Latest Developments
Table 53. GlaxoSmithKline Details, Company Type, Neurological Disorder Drugs Area Served and Its Competitors
Table 54. GlaxoSmithKline Neurological Disorder Drugs Product Offered
Table 55. GlaxoSmithKline Neurological Disorder Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. GlaxoSmithKline Main Business
Table 57. GlaxoSmithKline Latest Developments
Table 58. Merck & Co. Details, Company Type, Neurological Disorder Drugs Area Served and Its Competitors
Table 59. Merck & Co. Neurological Disorder Drugs Product Offered
Table 60. Merck & Co. Neurological Disorder Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Merck & Co. Main Business
Table 62. Merck & Co. Latest Developments
Table 63. Bayer Details, Company Type, Neurological Disorder Drugs Area Served and Its Competitors
Table 64. Bayer Neurological Disorder Drugs Product Offered
Table 65. Bayer Neurological Disorder Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Bayer Main Business
Table 67. Bayer Latest Developments
Table 68. AstraZeneca Details, Company Type, Neurological Disorder Drugs Area Served and Its Competitors
Table 69. AstraZeneca Neurological Disorder Drugs Product Offered
Table 70. AstraZeneca Neurological Disorder Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. AstraZeneca Main Business
Table 72. AstraZeneca Latest Developments
Table 73. Boehringer Ingelheim Details, Company Type, Neurological Disorder Drugs Area Served and Its Competitors
Table 74. Boehringer Ingelheim Neurological Disorder Drugs Product Offered
Table 75. Boehringer Ingelheim Neurological Disorder Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Boehringer Ingelheim Main Business
Table 77. Boehringer Ingelheim Latest Developments
Table 78. Teva Pharmaceutical Details, Company Type, Neurological Disorder Drugs Area Served and Its Competitors
Table 79. Teva Pharmaceutical Neurological Disorder Drugs Product Offered
Table 80. Teva Pharmaceutical Neurological Disorder Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Teva Pharmaceutical Main Business
Table 82. Teva Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Neurological Disorder Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neurological Disorder Drugs Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Neurological Disorder Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Neurological Disorder Drugs Sales Market Share by Country/Region (2024)
Figure 8. Neurological Disorder Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Neurological Disorder Drugs Market Size Market Share by Type in 2024
Figure 10. Neurological Disorder Drugs in Hospital
Figure 11. Global Neurological Disorder Drugs Market: Hospital (2020-2025) & ($ millions)
Figure 12. Neurological Disorder Drugs in Clinic
Figure 13. Global Neurological Disorder Drugs Market: Clinic (2020-2025) & ($ millions)
Figure 14. Global Neurological Disorder Drugs Market Size Market Share by Application in 2024
Figure 15. Global Neurological Disorder Drugs Revenue Market Share by Player in 2024
Figure 16. Global Neurological Disorder Drugs Market Size Market Share by Region (2020-2025)
Figure 17. Americas Neurological Disorder Drugs Market Size 2020-2025 ($ millions)
Figure 18. APAC Neurological Disorder Drugs Market Size 2020-2025 ($ millions)
Figure 19. Europe Neurological Disorder Drugs Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Neurological Disorder Drugs Market Size 2020-2025 ($ millions)
Figure 21. Americas Neurological Disorder Drugs Value Market Share by Country in 2024
Figure 22. United States Neurological Disorder Drugs Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Neurological Disorder Drugs Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Neurological Disorder Drugs Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Neurological Disorder Drugs Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Neurological Disorder Drugs Market Size Market Share by Region in 2024
Figure 27. APAC Neurological Disorder Drugs Market Size Market Share by Type (2020-2025)
Figure 28. APAC Neurological Disorder Drugs Market Size Market Share by Application (2020-2025)
Figure 29. China Neurological Disorder Drugs Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Neurological Disorder Drugs Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Neurological Disorder Drugs Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Neurological Disorder Drugs Market Size Growth 2020-2025 ($ millions)
Figure 33. India Neurological Disorder Drugs Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Neurological Disorder Drugs Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Neurological Disorder Drugs Market Size Market Share by Country in 2024
Figure 36. Europe Neurological Disorder Drugs Market Size Market Share by Type (2020-2025)
Figure 37. Europe Neurological Disorder Drugs Market Size Market Share by Application (2020-2025)
Figure 38. Germany Neurological Disorder Drugs Market Size Growth 2020-2025 ($ millions)
Figure 39. France Neurological Disorder Drugs Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Neurological Disorder Drugs Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Neurological Disorder Drugs Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Neurological Disorder Drugs Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Neurological Disorder Drugs Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Neurological Disorder Drugs Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Neurological Disorder Drugs Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Neurological Disorder Drugs Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Neurological Disorder Drugs Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Neurological Disorder Drugs Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Neurological Disorder Drugs Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Neurological Disorder Drugs Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 52. APAC Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 53. Europe Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 55. United States Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 56. Canada Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 57. Mexico Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 58. Brazil Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 59. China Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 60. Japan Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 61. Korea Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 63. India Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 64. Australia Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 65. Germany Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 66. France Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 67. UK Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 68. Italy Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 69. Russia Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 70. Egypt Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 71. South Africa Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 72. Israel Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 73. Turkey Neurological Disorder Drugs Market Size 2026-2031 ($ millions)
Figure 74. Global Neurological Disorder Drugs Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Neurological Disorder Drugs Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Neurological Disorder Drugs Market Size 2026-2031 ($ millions)